These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 4071419

  • 1. [Treatment of membranous glomerulonephritis].
    Stavskaia VV, Riabov SI.
    Ter Arkh; 1985; 57(6):74-8. PubMed ID: 4071419
    [Abstract] [Full Text] [Related]

  • 2. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa, Tomilina NA, Biriukova LS, Monchakovskiĭ SF.
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 4. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI, Stavskaia VV, Sheveleva LA.
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [Abstract] [Full Text] [Related]

  • 5. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N.
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [Abstract] [Full Text] [Related]

  • 6. [Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant].
    Ratner MIa, Tomilina NA, Klinkman Kh, Shmitt E, Kreger E.
    Ter Arkh; 1980; 52(8):106-10. PubMed ID: 7256574
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N.
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [Abstract] [Full Text] [Related]

  • 8. [Some problems of the therapy of chronic glomerulonephritis].
    Riabov SI, Stavskaia VV.
    Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
    [Abstract] [Full Text] [Related]

  • 9. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 10. Inverse relationship between serum cholinesterase activity and the administration of cyclophosphamide: an index of cyclophosphamide therapy.
    Imai H, Kodama T, Yasuda T, Nakamoto Y, Miura AB.
    Nephrol Dial Transplant; 1994; 9(9):1240-9. PubMed ID: 7816283
    [Abstract] [Full Text] [Related]

  • 11. Rapidly progressive glomerulonephritis with extensive crescents.
    Cameron JS, Ogg CS.
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):735-8. PubMed ID: 4807809
    [No Abstract] [Full Text] [Related]

  • 12. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA, Olmos A, Ferrer E, Mauri JM, Capdevilla L, Codina S, Alsina J, Camps J, Piera L.
    Rev Clin Esp; 1975 Dec 15; 139(5):415-22. PubMed ID: 1215585
    [No Abstract] [Full Text] [Related]

  • 13. [State of the blood prekallikrein-kallikrein system in patients with glomerulonephritis as affected by pathogenetic therapy].
    Petrun' NM, Pyrig LA, Krimkevich EI.
    Ter Arkh; 1985 Dec 15; 57(6):84-6. PubMed ID: 3852551
    [Abstract] [Full Text] [Related]

  • 14. Indomethacin treatment of membranoproliferative and lobular glomerulonephritis.
    Michielsen P, Van Damme B, Dotremont G, Verberckmoes R, Oei LS, Vermylen J.
    Perspect Nephrol Hypertens; 1973 Dec 15; 1 Pt 1():611-31. PubMed ID: 4536442
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of primary membranous-proliferative glomerulonephritis].
    Martínez Ara J, Rivero Sánchez M, Miguel Alonso JL, Riñón Aguilar C, Almaraz Jiménez MA, Sanz Guajardo A, Sánchez Sicilia L.
    Rev Clin Esp; 1975 Oct 15; 139(1):61-7. PubMed ID: 1197831
    [No Abstract] [Full Text] [Related]

  • 16. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa, Fedorova ND.
    Urol Nefrol (Mosk); 1996 Oct 15; (2):32-5. PubMed ID: 8677550
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide.
    Vanrenterghem Y, Roels L, Verberckmoes R, Michielsen P.
    Clin Nephrol; 1975 Dec 15; 4(6):218-22. PubMed ID: 1204260
    [Abstract] [Full Text] [Related]

  • 18. [Special pharmacotherapy of primary glomerulonephritis in the adult].
    Thiele KG.
    Dtsch Med Wochenschr; 1975 Sep 05; 100(36):1803-4. PubMed ID: 1157682
    [No Abstract] [Full Text] [Related]

  • 19. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Biriukova LS, Makurov AI.
    Ter Arkh; 1992 Sep 05; 64(8):47-50. PubMed ID: 1440396
    [No Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
    Nephrol Dial Transplant; 2009 Oct 05; 24(10):3082-8. PubMed ID: 19465558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.